Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Debopam Samanta

Concepts (308)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
21
2022
187
13.150
Why?
Seizures
16
2022
198
5.040
Why?
Spasms, Infantile
8
2022
31
4.280
Why?
Cannabidiol
5
2022
34
4.100
Why?
Status Epilepticus
6
2021
37
3.940
Why?
Tuberous Sclerosis
6
2022
37
3.890
Why?
Anticonvulsants
11
2022
135
3.360
Why?
Mutation
15
2022
1432
3.270
Why?
Electroencephalography
17
2022
360
2.660
Why?
Epilepsies, Myoclonic
4
2020
11
2.640
Why?
Intellectual Disability
4
2019
137
2.420
Why?
Hemiplegia
3
2021
11
2.420
Why?
Humans
93
2022
53032
2.410
Why?
Brain
9
2019
1467
2.190
Why?
Developmental Disabilities
5
2019
127
2.010
Why?
Epilepsy, Absence
3
2019
11
1.970
Why?
Child
30
2022
6933
1.960
Why?
Magnetic Resonance Imaging
15
2019
1724
1.740
Why?
Neuroaxonal Dystrophies
2
2022
8
1.680
Why?
Nervous System Malformations
3
2020
17
1.660
Why?
Folate Receptor 1
2
2022
23
1.640
Why?
Infant, Newborn, Diseases
2
2020
57
1.530
Why?
Epilepsies, Partial
2
2022
13
1.530
Why?
Ketamine
2
2020
62
1.500
Why?
Neurocutaneous Syndromes
2
2019
7
1.370
Why?
Cadherins
2
2019
79
1.320
Why?
Infant
16
2022
3697
1.320
Why?
Cerebral Arteries
2
2019
42
1.260
Why?
Sirolimus
2
2017
64
1.210
Why?
Child, Preschool
16
2021
4144
1.190
Why?
Angiofibroma
2
2015
5
1.180
Why?
Facial Neoplasms
2
2015
24
1.160
Why?
Valproic Acid
2
2022
33
1.140
Why?
Nerve Tissue Proteins
2
2018
216
1.120
Why?
Stroke
3
2019
531
1.030
Why?
Landau-Kleffner Syndrome
1
2022
3
0.970
Why?
Aphasia
1
2022
23
0.950
Why?
Male
32
2021
28343
0.940
Why?
Quality Improvement
2
2022
233
0.910
Why?
Nervous System Diseases
2
2021
97
0.890
Why?
Female
27
2021
28983
0.880
Why?
Chromosome Deletion
3
2019
150
0.880
Why?
Emergencies
1
2021
96
0.840
Why?
Transition to Adult Care
1
2020
12
0.840
Why?
Angelman Syndrome
1
2020
2
0.840
Why?
Pharmaceutical Preparations
1
2021
87
0.830
Why?
Immunoglobulins, Intravenous
1
2021
58
0.810
Why?
Fenfluramine
1
2020
7
0.800
Why?
Oligonucleotides, Antisense
1
2020
32
0.800
Why?
Phenobarbital
1
2020
20
0.790
Why?
Dioxolanes
1
2020
13
0.790
Why?
Pregnanolone
1
2019
5
0.790
Why?
Flunarizine
1
2019
1
0.790
Why?
Behavioral Symptoms
1
2019
6
0.790
Why?
Excitatory Amino Acid Antagonists
1
2020
57
0.780
Why?
Ocular Physiological Phenomena
1
2019
5
0.770
Why?
Tetrasomy
1
2019
2
0.770
Why?
Agenesis of Corpus Callosum
2
2018
9
0.770
Why?
Immunologic Factors
1
2021
129
0.770
Why?
Chromosomes, Human, Pair 5
1
2019
17
0.770
Why?
Sneddon Syndrome
1
2019
3
0.760
Why?
Livedo Reticularis
1
2019
5
0.760
Why?
Oral Ulcer
1
2019
3
0.760
Why?
Behcet Syndrome
1
2019
6
0.760
Why?
Calcium Channel Blockers
1
2019
70
0.750
Why?
Transposases
1
2019
10
0.750
Why?
Andersen Syndrome
1
2019
1
0.750
Why?
Hydrocephalus
1
2019
38
0.750
Why?
Genetic Therapy
1
2020
117
0.740
Why?
Nephrotic Syndrome
2
2017
20
0.740
Why?
Vitiligo
1
2019
8
0.740
Why?
Receptors, GABA-B
1
2019
10
0.740
Why?
Spinal Cord Diseases
1
2019
40
0.740
Why?
Autoimmune Diseases of the Nervous System
1
2019
10
0.740
Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.730
Why?
Leukoencephalopathies
1
2019
17
0.730
Why?
Migraine Disorders
2
2020
51
0.730
Why?
Optic Atrophy
1
2018
11
0.730
Why?
Cannabinoid Receptor Agonists
1
2019
43
0.720
Why?
Cerebral Infarction
1
2018
36
0.720
Why?
Muscle Weakness
1
2019
48
0.720
Why?
Electron Transport Complex IV
1
2018
41
0.720
Why?
Edema
1
2019
67
0.720
Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.720
Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.720
Why?
Shab Potassium Channels
1
2018
2
0.720
Why?
Treatment Outcome
7
2022
5645
0.710
Why?
Alopecia
1
2019
54
0.710
Why?
Photic Stimulation
1
2018
72
0.710
Why?
Physicians
1
2022
236
0.710
Why?
Brain Edema
1
2018
43
0.700
Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
25
0.690
Why?
Myoclonus
1
2018
11
0.690
Why?
Parents
1
2021
350
0.690
Why?
Artifacts
1
2018
63
0.680
Why?
Tumor Suppressor Proteins
2
2016
146
0.680
Why?
Thrombocytopenia
1
2019
95
0.680
Why?
Mitochondrial Diseases
1
2018
46
0.680
Why?
Biomedical Research
1
2021
245
0.680
Why?
Neurodegenerative Diseases
1
2018
80
0.670
Why?
Autoimmune Diseases
1
2019
112
0.670
Why?
Hearing Loss, Sensorineural
1
2018
73
0.650
Why?
Abnormalities, Multiple
2
2019
169
0.650
Why?
Osteochondrodysplasias
1
2017
15
0.650
Why?
Immunologic Deficiency Syndromes
1
2017
21
0.650
Why?
Practice Guidelines as Topic
1
2020
537
0.640
Why?
Arteriosclerosis
1
2017
62
0.640
Why?
Carotid Artery Diseases
1
2017
38
0.640
Why?
Drug Discovery
1
2017
94
0.620
Why?
Child Development
1
2018
214
0.620
Why?
Cafe-au-Lait Spots
1
2016
2
0.620
Why?
Phenotype
2
2021
842
0.610
Why?
Prenatal Exposure Delayed Effects
1
2018
210
0.610
Why?
Health Knowledge, Attitudes, Practice
1
2021
572
0.600
Why?
Erythema Infectiosum
1
2015
3
0.600
Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.600
Why?
Migraine with Aura
1
2015
5
0.600
Why?
Williams Syndrome
1
2016
28
0.600
Why?
Sinus Pericranii
1
2015
1
0.600
Why?
Models, Biological
1
2020
869
0.590
Why?
Parvovirus B19, Human
1
2015
17
0.590
Why?
SOS1 Protein
1
2015
2
0.590
Why?
Crying
1
2015
4
0.590
Why?
Toes
1
2015
21
0.590
Why?
Moyamoya Disease
1
2015
7
0.590
Why?
Electrodiagnosis
1
2015
15
0.590
Why?
Infant, Newborn
5
2020
2770
0.590
Why?
Skin
1
2019
443
0.590
Why?
Hyperventilation
1
2015
8
0.590
Why?
Iatrogenic Disease
1
2015
28
0.590
Why?
Tuberculoma
1
2015
3
0.590
Why?
Pulmonary Embolism
1
2017
105
0.580
Why?
Epilepsy, Benign Neonatal
1
2015
3
0.580
Why?
Noonan Syndrome
1
2015
12
0.580
Why?
Mutism
1
2015
3
0.570
Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.570
Why?
Neurologic Examination
1
2015
84
0.570
Why?
Encephalitis
1
2016
49
0.570
Why?
Ocular Motility Disorders
1
2015
25
0.570
Why?
Communication
3
2022
262
0.570
Why?
TOR Serine-Threonine Kinases
1
2015
88
0.560
Why?
Bone Diseases, Developmental
1
2014
12
0.560
Why?
Tooth Abnormalities
1
2014
11
0.560
Why?
Adolescent
11
2020
6886
0.560
Why?
Trisomy
1
2014
36
0.550
Why?
Energy Drinks
1
2014
7
0.540
Why?
Influenza, Human
1
2015
83
0.540
Why?
KCNQ2 Potassium Channel
1
2014
17
0.540
Why?
Corpus Callosum
1
2014
27
0.540
Why?
Neurology
1
2015
46
0.530
Why?
Vasoconstriction
1
2014
62
0.530
Why?
Benzodiazepines
1
2014
71
0.530
Why?
Syndrome
5
2020
260
0.530
Why?
Diagnosis, Differential
7
2020
1185
0.530
Why?
Osteomyelitis
1
2015
128
0.530
Why?
Membrane Proteins
1
2016
390
0.490
Why?
Repressor Proteins
1
2014
171
0.490
Why?
Sleep
1
2014
192
0.480
Why?
Enzyme Inhibitors
1
2015
471
0.470
Why?
Magnetic Resonance Angiography
3
2019
90
0.470
Why?
Immunosuppressive Agents
3
2019
260
0.450
Why?
Pediatrics
1
2015
319
0.420
Why?
Quality of Life
3
2022
821
0.420
Why?
Receptors, N-Methyl-D-Aspartate
2
2022
126
0.410
Why?
Diffusion Magnetic Resonance Imaging
3
2017
130
0.400
Why?
Caregivers
2
2021
211
0.370
Why?
Recurrence
3
2019
698
0.360
Why?
Echinocandins
1
2008
62
0.350
Why?
Mycoses
1
2008
154
0.330
Why?
Gastroesophageal Reflux
2
2019
49
0.320
Why?
Administration, Topical
2
2015
70
0.290
Why?
Antifungal Agents
1
2008
343
0.290
Why?
Speech Disorders
1
2022
19
0.240
Why?
Ethosuximide
1
2022
4
0.240
Why?
Clonazepam
1
2022
5
0.240
Why?
Electrodes, Implanted
1
2022
26
0.240
Why?
Stereotaxic Techniques
1
2022
35
0.240
Why?
Death, Sudden
1
2022
18
0.230
Why?
Retrospective Studies
4
2021
6076
0.230
Why?
GTPase-Activating Proteins
1
2022
22
0.230
Why?
Concept Formation
1
2021
13
0.230
Why?
Freedom
1
2021
3
0.220
Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
5
0.220
Why?
Diazepam
1
2021
17
0.220
Why?
Folic Acid
1
2022
137
0.220
Why?
Drug Interactions
1
2022
220
0.220
Why?
Fibroma
1
2021
43
0.220
Why?
Adrenocorticotropic Hormone
2
2022
41
0.210
Why?
Dihydroergotamine
1
2020
5
0.210
Why?
Personal Satisfaction
1
2021
88
0.210
Why?
Soft Tissue Neoplasms
1
2021
71
0.210
Why?
Brain Diseases
1
2021
96
0.210
Why?
Diet Therapy
1
2020
9
0.200
Why?
Risk Factors
2
2020
4007
0.200
Why?
Qualitative Research
1
2021
318
0.200
Why?
Genetic Diseases, Inborn
1
2020
24
0.200
Why?
Perception
1
2021
150
0.200
Why?
Consensus
1
2021
146
0.200
Why?
Ubiquitin-Protein Ligases
1
2020
100
0.200
Why?
Anesthetics
1
2020
37
0.190
Why?
Clinical Protocols
1
2020
130
0.190
Why?
Treatment Failure
1
2020
136
0.190
Why?
Leukomalacia, Periventricular
1
2019
13
0.190
Why?
Matrix Attachment Region Binding Proteins
1
2020
31
0.190
Why?
Muscle Hypotonia
1
2019
22
0.190
Why?
Chromosomes, Human, Pair 7
1
2019
30
0.190
Why?
HLA-B51 Antigen
1
2019
2
0.190
Why?
Ventriculoperitoneal Shunt
1
2019
25
0.190
Why?
Learning
1
2021
165
0.190
Why?
Craniofacial Abnormalities
1
2019
29
0.190
Why?
Heart Septal Defects, Atrial
1
2019
44
0.190
Why?
Ventricular Premature Complexes
1
2019
4
0.190
Why?
Potassium Channels, Inwardly Rectifying
1
2019
6
0.190
Why?
Patient-Centered Care
1
2021
134
0.190
Why?
Microcephaly
1
2019
42
0.180
Why?
Analgesics, Non-Narcotic
1
2020
148
0.180
Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.180
Why?
Facial Nerve Diseases
1
2018
6
0.180
Why?
Randomized Controlled Trials as Topic
1
2022
545
0.180
Why?
Nocturnal Myoclonus Syndrome
1
2018
14
0.180
Why?
Facial Paralysis
1
2018
18
0.180
Why?
Disease Management
1
2020
200
0.180
Why?
Syncope
1
2019
35
0.180
Why?
Cerebral Veins
1
2018
18
0.180
Why?
Referral and Consultation
1
2021
307
0.180
Why?
Deglutition Disorders
1
2019
75
0.180
Why?
Anti-Arrhythmia Agents
1
2019
96
0.170
Why?
Frameshift Mutation
1
2018
17
0.170
Why?
Video Recording
1
2018
96
0.170
Why?
Health Personnel
1
2021
235
0.170
Why?
Acute Disease
1
2019
419
0.170
Why?
Fatal Outcome
1
2019
235
0.170
Why?
Fear
1
2018
93
0.170
Why?
Fibrinolytic Agents
1
2019
149
0.170
Why?
India
1
2017
81
0.170
Why?
Anti-Inflammatory Agents
1
2019
179
0.170
Why?
Clinical Trials as Topic
1
2020
502
0.170
Why?
Combined Modality Therapy
1
2020
713
0.170
Why?
History, 21st Century
1
2017
67
0.170
Why?
Methotrexate
1
2017
76
0.160
Why?
Cerebellum
1
2018
141
0.160
Why?
History, 20th Century
1
2017
127
0.160
Why?
Neurotoxicity Syndromes
1
2017
54
0.160
Why?
Platelet Aggregation Inhibitors
1
2019
210
0.160
Why?
Pandemics
1
2021
464
0.150
Why?
Anti-Infective Agents
1
2017
109
0.150
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
104
0.150
Why?
Aldehyde Dehydrogenase
1
2016
28
0.150
Why?
Influenza B virus
1
2015
6
0.150
Why?
Hormones
1
2016
66
0.150
Why?
Adult
3
2021
14382
0.150
Why?
Delayed Diagnosis
1
2016
24
0.150
Why?
Chromosomes, Human, Pair 3
1
2015
21
0.150
Why?
Transcription Factors
1
2020
640
0.150
Why?
North America
1
2015
71
0.150
Why?
Animals
3
2022
14806
0.140
Why?
Arkansas
1
2021
2193
0.140
Why?
Facies
1
2014
34
0.140
Why?
Chromosomes, Human, Pair 9
1
2014
22
0.140
Why?
Cerebral Angiography
1
2015
110
0.140
Why?
Brain Waves
1
2014
23
0.140
Why?
Antibiotics, Antineoplastic
1
2015
85
0.140
Why?
Complementary Therapies
1
2015
33
0.140
Why?
Drug Resistance
1
2015
81
0.140
Why?
Antiemetics
1
2014
33
0.130
Why?
Headache
1
2014
78
0.130
Why?
Vomiting
1
2014
72
0.130
Why?
Glutamine
1
2015
171
0.130
Why?
Mutation, Missense
1
2014
117
0.130
Why?
Polymerase Chain Reaction
1
2015
554
0.130
Why?
Decision Making, Computer-Assisted
1
2013
5
0.130
Why?
Arginine
1
2015
188
0.120
Why?
Analgesics
1
2014
112
0.120
Why?
Vigabatrin
2
2022
2
0.120
Why?
Diagnostic Errors
1
2013
74
0.120
Why?
Evidence-Based Medicine
1
2013
309
0.110
Why?
Pregnancy
1
2018
2432
0.110
Why?
Inflammation
1
2016
671
0.100
Why?
Signal Transduction
1
2017
1850
0.100
Why?
Dysentery
1
2009
1
0.090
Why?
Trichuriasis
1
2009
1
0.090
Why?
Trichuris
1
2009
1
0.090
Why?
Anesthesia, Intravenous
1
2008
13
0.090
Why?
Eosinophils
1
2009
38
0.090
Why?
Antineoplastic Agents
1
2017
1290
0.090
Why?
Lipopeptides
1
2008
64
0.090
Why?
Amyloidosis
1
2009
83
0.090
Why?
Inflammatory Bowel Diseases
1
2009
53
0.090
Why?
Tuberculosis
1
2009
127
0.090
Why?
Candidiasis
1
2008
117
0.080
Why?
Aspergillosis
1
2008
136
0.080
Why?
Kidney Diseases
1
2009
305
0.070
Why?
Potassium Channels
1
2021
38
0.060
Why?
Administration, Intravenous
1
2020
82
0.050
Why?
Sleep Stages
1
2020
49
0.050
Why?
Age of Onset
1
2020
121
0.050
Why?
Cognition
1
2022
354
0.050
Why?
Immunohistochemistry
1
2021
1143
0.040
Why?
Prospective Studies
1
2022
2452
0.040
Why?
Software
1
2013
281
0.030
Why?
Internet
1
2013
302
0.020
Why?
Young Adult
1
2020
4310
0.020
Why?
Antinematodal Agents
1
2009
2
0.020
Why?
Mebendazole
1
2009
2
0.020
Why?
Leukemoid Reaction
1
2009
8
0.020
Why?
Antitubercular Agents
1
2009
97
0.020
Why?
Colonoscopy
1
2009
115
0.020
Why?
Prognosis
1
2009
2105
0.020
Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description